Projects

Soukhya- Celebrating Life

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2021 - 2024

Project Lead

Dr. Farah Naaz Fathima

Authors

Dr. Farah Naaz Fathima, Dr. B Ramakrishna Goud, Dr. Avita Rose Johnson, Dr. Pooja R Sridhar

Project Status

completed

Project Type

CSR funded project